Sensitive Detection and Quantification of the JAK2V617F Allele by Real-Time PCR: Blocking Wild-Type Amplification by Using a Peptide Nucleic Acid Oligonucleotide

作者: Cornelis J.J. Huijsmans , Jeroen Poodt , Paul H.M. Savelkoul , Mirjam H.A. Hermans

DOI: 10.1016/J.JMOLDX.2011.04.002

关键词:

摘要: A single G-to-T missense mutation in the gene for JAK2 tyrosine kinase, leading to a V617F amino acid substitution, is commonly found several myeloproliferative neoplasms. Reliable quantification of this mutant allele increasing clinical and therapeutic interest predicting diagnosing group Because JAK2V617F somatically acquired may be followed by loss heterozygosity, percentage versus wild-type DNA blood can vary between 0% almost 100%. Therefore, we developed real-time PCR assay detection low-to-high range burden. To allow meet these criteria, amplification was blocked with peptide nucleic oligonucleotide. patient diluted could amplified linearly from 0.05% 100%, acceptable reproducibility quantification. The sensitivity (n = 3 3). In 9 100 healthy donors, weak positive/background signal observed isolated blood, corresponding approximately 0.01% allele. one individual, duplicate. relevance finding not clear. By inhibiting allele, sensitive linear detect quantify JAK2V617F.

参考文章(62)
Letter: Bone-marrow responses in polycythemia vera. The New England Journal of Medicine. ,vol. 290, pp. 1382- ,(1974) , 10.1056/NEJM197406132902419
Emma Hammond, Kathryn Shaw, Benedict Carnley, Stephanie P'ng, Ian James, Richard Herrmann, Quantitative Determination of JAK2 V617F by TaqMan: An Absolute Measure of Averaged Copies per Cell That May Be Associated with the Different Types of Myeloproliferative Disorders The Journal of Molecular Diagnostics. ,vol. 9, pp. 242- 248 ,(2007) , 10.2353/JMOLDX.2007.060125
Bobbie Collett Sutton, Richard A. Allen, Zhizhuang Joe Zhao, S. Terence Dunn, Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis. Cancer Biomarkers. ,vol. 3, pp. 315- 324 ,(2007) , 10.3233/CBM-2007-3605
Marcus Kremer, Thomas Horn, Ina Koch, Tobias Dechow, Stefan Gattenloehner, Walter Pfeiffer, Leticia Quintanilla-Martínez, Falko Fend, Quantitation of the JAK2V617F mutation in microdissected bone marrow trephines: equal mutational load in myeloid lineages and rare involvement of lymphoid cells. The American Journal of Surgical Pathology. ,vol. 32, pp. 928- 935 ,(2008) , 10.1097/PAS.0B013E31815D6305
Dina Shammaa, Ali Bazarbachi, Hussein Halas, Layal Greige, Rami Mahfouz, JAK2 V617F Mutation Detection: Laboratory Comparison of Two Kits Using RFLP and qPCR Genetic Testing and Molecular Biomarkers. ,vol. 14, pp. 13- 15 ,(2010) , 10.1089/GTMB.2009.0119
Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro Rambaldi, Giovanni Barosi, Roberto Marchioli, Rosa Maria Marfisi, Guido Finazzi, Vittoria Guerini, Fabrizio Fabris, Maria Luigia Randi, Valerio De Stefano, Sabrina Caberlon, Agostino Tafuri, Marco Ruggeri, Giorgina Specchia, Vincenzo Liso, Edoardo Rossi, Enrico Pogliani, Luigi Gugliotta, Alberto Bosi, Tiziano Barbui, Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood. ,vol. 110, pp. 840- 846 ,(2007) , 10.1182/BLOOD-2006-12-064287
Avichai Shimoni, Asaf Vivante, Luba Trakhtenbrot, Gideon Rechavi, Ninette Amariglio, Ron Loewenthal, Arnon Nagler, Yoram Cohen, A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leukemia Research. ,vol. 32, pp. 421- 427 ,(2008) , 10.1016/J.LEUKRES.2007.07.003